POINT Biopharma Global Inc.
PNTDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811764
POINT Biopharma Global Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Dec 27, 2023; 126 institutions reported holding it in 13F filings for Q3 2023, worth $411.0M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding POINT Biopharma Global Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 34 | 55 | +21 |
| Shares | 32.2M | 34.7M | +2.50M (+7.8%) |
| Value | $247.7M | $194.4M | −$53.3M (−21.5%) |
New holders (25)
Institutions that held POINT Biopharma Global Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (4)
Institutions that held POINT Biopharma Global Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Berylson Capital Partners, LLC | 386,221 | $2.97M |
| Chicago Partners Investment Group LLC | 10,295 | $92.0K |
| Point72 Hong Kong Ltd | 8,241 | $63.0K |
| Cubist Systematic Strategies, LLC | 3,637 | $28.0K |